The effect of the Janus kinase-1 inhibitor filgotinib in proinflammatory cytokine production by ex-vivo myeloid and synovial derived cells from rheumatoid arthritis patients. Comparison to upadacitinib, tofacitinib and baricitinib
Weston S., MacDonald J., Kang N., Kiriakidis S., Taylor PC.